Recorded Chinese product: 复方氨基酸注射液(15-HBC)复方氨基酸注射液(15-HBC)

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

L 电解质浓度(mmol是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:l 电解质浓度(mmol、丙氨酸Bingan Suan、丝氨酸Sian Suan、亮氨酸Liangan Suan、其他氨基酸为%。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:l 电解质浓度(mmol-e58485fb成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 复方氨基酸注射液(15-HBC)) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: l, 丙氨酸Bingan Suan, 丝氨酸Sian Suan, 亮氨酸Liangan Suan, %.

Explore other medicines containing the same ingredient: l 电解质浓度(mmol productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 复方氨基酸注射液(15-HBC)Recorded Chinese product: 复方氨基酸注射液(15-HBC)
  • 规格Specification: 250ml:17.25g(总氨基酸)Recorded Chinese specification: 250ml:17.25g(总氨基酸)

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 浙江济民制药有限公司Chinese legal name: 浙江济民制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20013170

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20013170

Manufacturer

Chinese legal name: 浙江济民制药有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20013170

生产企业

浙江济民制药有限公司(国产)

适应症

本品用于大面积烧伤、创伤及严重感染等应激状态下肌肉分解代谢亢进、消化系统功能障碍、营养恶化及免疫功能下降病人的营养支持;以及用于手术后病人营养的改善。

用法用量

1.静滴,用量根据病人的年龄、体重、营养状态及病情而定,一般250―1000m1/d。 2.经中心静脉长时间应用时与高渗葡萄糖或脂肪乳、维生素、电解质、微量元素等注射液联用,以达到营养支持的目的。 3.由外周静脉输注时可用5%葡萄糖注射液稀释后缓慢滴注,速度以每分钟30一40滴为宜。

不良反应

输注过快或过浓时,可产生呕吐、发热等不良反应。由于含有抗氧化剂焦亚硫酸钠,因此偶可诱发过敏反应(尤其哮喘病人)。

禁忌

尚不明确。

注意事项

1. 使用时应监测肝功能,肝功能明显异常时慎用;严重肝、肾功能损害的病人不宜使用。2. 使用前应仔细检查药液,如有药液浑浊、生霉、瓶身和瓶口破裂、封口松动漏气等情况时切勿使用。3. 药液应一次用完,剩余药液不可再用。4. 本品遇冷析出结晶,用前可浸泡于40~50℃温水中使其溶解,放至体温后再用。

贮藏

密闭,置凉暗处保存。

规格

250ml:17.25g(总氨基酸)

证据Evidence

  • 批准文号: 国药准字H20013170
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.